Repository logo
 

Exploring the impact of metabolic imaging in head and neck cancer treatment.

Simple item page
cam.issuedOnline2022-07
dc.contributor.authorDias Domingues, Diana Raquel
dc.contributor.authorLeech, Michelle M
dc.contributor.orcidDias Domingues, Diana Raquel [0000-0001-7799-8428]
dc.date.accessioned2022-07-01T13:00:06Z
dc.date.available2022-07-01T13:00:06Z
dc.date.issued2022-10
dc.date.submitted2022-02-09
dc.date.updated2022-07-01T13:00:06Z
dc.description.abstractBACKGROUND: Target volume delineation is performed with anatomical imaging for head and neck cancer. Molecular imaging allows the recognition of specific tumor regions. Its inclusion in the pathway could lead to changes in delineation and resultant treatment plans. METHODS: PRISMA methodology was adhered to when selecting the articles for analysis and only full articles were quality assessed. RESULTS: Seventeen articles were included. Gross tumor volume (GTV) primary, GTV nodal, and other target volumes were evaluated. Positron emission tomography/computerized tomography (PET/CT) produced smaller primary GTVs, although not with diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI) or PET/MRI. The impact of these image modalities on GTV nodal did not display any consistency. Additionally, there was considerable heterogeneity in metrics comparing delineations. Four studies included appraised the dosimetric impact of the changes in target volume delineation. CONCLUSION: Quantifying the impact of molecular imaging is difficult, due to heterogeneity in reporting metrics in molecular imaging modalities and a paucity of detail regarding delineation method and guideline adherence.
dc.identifier.doi10.17863/CAM.86068
dc.identifier.eissn1097-0347
dc.identifier.issn1043-3074
dc.identifier.otherhed27131
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/338657
dc.languageen
dc.language.isoeng
dc.publisherWiley
dc.publisher.urlhttp://dx.doi.org/10.1002/hed.27131
dc.subjectdelineation
dc.subjecthead and neck
dc.subjectimaging
dc.subjectmetabolic
dc.subjectradiotherapy
dc.subjectFluorodeoxyglucose F18
dc.subjectHead and Neck Neoplasms
dc.subjectHumans
dc.subjectMagnetic Resonance Imaging
dc.subjectPositron Emission Tomography Computed Tomography
dc.subjectPositron-Emission Tomography
dc.subjectRadiotherapy Planning, Computer-Assisted
dc.subjectTomography, X-Ray Computed
dc.subjectTumor Burden
dc.titleExploring the impact of metabolic imaging in head and neck cancer treatment.
dc.typeArticle
dcterms.dateAccepted2022-06-16
prism.publicationNameHead Neck
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1002/hed.27131

Files

Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
hed.27131.xml
Size:
6.84 KB
Format:
Extensible Markup Language
Description:
Bibliographic metadata
Licence
http://creativecommons.org/licenses/by-nc-nd/4.0/
Download
Thumbnail Image
Name:
hed.27131.pdf
Size:
1.69 MB
Format:
Adobe Portable Document Format
Description:
Published version
Licence
http://creativecommons.org/licenses/by-nc-nd/4.0/
Download

Collections

Jisc Publications Router